{"data":{"id":"us-wa/rcw-74.09.559","jurisdiction":"us-wa","citation":"RCW 74.09.559","heading":"Long-acting injectable buprenorphine—Billing codes—Reimbursement.","body":"(1) The authority shall establish appropriate billing codes for hospitals and psychiatric hospitals that administer long-acting injectable buprenorphine on an outpatient basis to use for billing patients enrolled in a medical assistance program.\n(2) Upon initiation or renewal of a contract with the authority to administer a medicaid managed care plan, a managed care organization must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis as a separate reimbursable expense.\n(3) Beginning January 1, 2025, for individuals enrolled in a medical assistance program that is not a medicaid managed care plan, the authority must reimburse a hospital or psychiatric hospital that bills for the administration of long-acting injectable buprenorphine on an outpatient basis administered as a separate reimbursable expense.\n(4) Reimbursements provided under this section must be separate from any bundled payment for outpatient hospital or emergency department services.","path":["Title 74","Chapter 74.09"],"source_url":"https://app.leg.wa.gov/rcw/default.aspx?cite=74.09.559","current_through":"July 15, 2026","vintage":"","retrieved_at":"2026-09-06T04:10:01Z","sha256":"b2bbfa42bbb9f9ec85765373f351becc62e1a5e97544185b9ffd7f92716c8cb0","source_id":"us-wa","stale":false,"prev":"us-wa/rcw-74.09.557","next":"us-wa/rcw-74.09.565"},"notice":"GroundRules: Original legal text. Not legal advice."}